bioAffinity Technologies Inc Share Price Today: Live Updates & Key Insights

bioAffinity Technologies Inc share price today is $0.667, up -1.18%. The stock opened at $0.6595 against the previous close of $0.6678, with an intraday high of $0.69 and low of $0.6487.

bioAffinity Technologies Inc Share Price Chart

bioAffinity Technologies Inc

us-stock
To Invest in {{usstockname}}
us-stock

bioAffinity Technologies Inc Share Price Performance

$0.667 -0.0118(-1.18%) BIAF at 27 Jul 2026 02:11 PM Diagnostics & Research
Lowest Today 0.6487
Highest Today 0.69
Today’s Open 0.6595
Prev. Close 0.6678
52 Week High 13.50
52 Week Low 0.61
Day’s Range: Low 0.6487 High 0.69
52-Week Range: Low 0.61 High 13.50
1 day return -
1 Week return -3.86
1 month return -22.55
3 month return -70.68
6 month return -49.71
1 year return +98.09
3 year return -64.08
5 year return -
10 year return -

bioAffinity Technologies Inc Institutional Holdings

Blackrock Extended Mkt Fund CF 1.57

BlackRock Extended Equity Market Fund K 1.34

Vanguard Capital Management, LLC 0.88

Vanguard Institutional Extnd Mkt Idx Tr 0.88

Geode Capital Management, LLC 0.77

J. Safra Sarasin Holding AG 0.68

Vanguard Fiduciary Trust Co 0.49

Fidelity Extended Market Index 0.45

Schonfeld Strategic Advisors LLC 0.39

State Street Corp 0.23

Northern Trust Corp 0.20

Northern Trust Extended Eq Market Idx 0.20

NT Ext Equity Mkt Index Fund - Lending 0.20

DFA US Small Cap I 0.17

Extended Equity Market Fund M 0.16

UBS Group AG 0.15

Fidelity Total Market Index 0.12

Fidelity Series Total Market Index 0.10

Spartan Extended Market Index Pool F 0.10

NT Ext Eq Mkt Idx Fd DC Lending Tier 5 0.08

NT Ext Equity Mkt Index Fund - NL 0.07

DFA US Micro Cap I 0.06

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.05

Fidelity Nasdaq Composite Index 0.05

Spartan Total Market Index Pool G 0.05

Tower Research Capital LLC 0.03

Ameritas Advisory Services, LLC 0.02

IFP Advisors, LLC 0.01

Citigroup Inc 0.00

Caitong International Asset Management Co., Limited. 0.00

Citadel Advisors Llc 0.00

FMR Inc 0.00

Hanson Mcclain Inc 0.00

Larson Financial Group, LLC 0.00

Morgan Stanley - Brokerage Accounts 0.00

Sabby Management LLC 0.00

Scientech Research LLC 0.00

bioAffinity Technologies Inc Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

bioAffinity Technologies Inc Fundamentals

Market Cap 4.20 M

PB Ratio 1.2012

PE Ratio 0.0

Enterprise Value 2.68 M

Total Assets 10.96 M

Volume 131172

bioAffinity Technologies Inc Company Financials

Annual Revenue FY23:321489 0.3M, FY22:4803 0.0M, FY21:0 0.0M, FY20:0 0.0M

Annual Profit FY23:245289 0.2M, FY22:4336 0.0M, FY21:null 0.0M, FY20:null 0.0M

Annual Net worth FY23:-7238430 -7.2M, FY22:-8154113 -8.2M, FY21:-6326413 -6.3M, FY20:-7268737 -7.3M

Quarterly Revenue Q1/2026:1351527 1.4M, Q3/2025:1446066 1.4M, Q2/2025:1269483 1.3M, Q1/2025:1853597 1.9M, Q3/2024:2350386 2.4M

Quarterly Profit Q1/2026:308373 0.3M, Q3/2025:390495 0.4M, Q2/2025:252881 0.3M, Q1/2025:485737 0.5M, Q3/2024:910228 0.9M

Quarterly Net worth Q1/2026:-3630610 -3.6M, Q3/2025:-5051084 -5.1M, Q2/2025:-4060787 -4.1M, Q1/2025:-2660417 -2.7M, Q3/2024:-2000840 -2.0M

About bioAffinity Technologies Inc & investment objective

Company Information bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

Organisation Diagnostics & Research

Employees 57

Industry Diagnostics & Research

CEO Ms. Maria Zannes J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

bioAffinity Technologies Inc FAQs

What is the share price of bioAffinity Technologies Inc today?

The current share price of bioAffinity Technologies Inc is $0.667.

Can I buy bioAffinity Technologies Inc shares in India?

Yes, Indian investors can buy bioAffinity Technologies Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy bioAffinity Technologies Inc shares in India?

You can easily invest in bioAffinity Technologies Inc shares from India by:

Can I buy fractional shares of bioAffinity Technologies Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of bioAffinity Technologies Inc?

bioAffinity Technologies Inc has a market cap of $4.20 M.

In which sector does bioAffinity Technologies Inc belong?

bioAffinity Technologies Inc operates in the Diagnostics & Research sector.

What documents are required to invest in bioAffinity Technologies Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of bioAffinity Technologies Inc?

The PE ratio of bioAffinity Technologies Inc is N/A and the PB ratio is 1.20.